Pronova BioPharma Release: Strengthened Position Following Intellectual Property and Regulatory Approvals

Published: May 07, 2010

7 May 2010, Lysaker, Norway: Pronova BioPharma ASA (OSE: PRON.OL) reports further solid progress in the first quarter of 2010, with total revenues of NOK 455.4 million and EBITDA of NOK 185.2 million. Total shipments in the quarter reached 468 tonnes. The group's position has been further strengthened, as patents have been granted in Europe for the group's proprietary stripping technology for the removal of

Back to news